Infectious disease news - the latest biotech news from Labiotech.eu

Home Infectious disease

Latest Posts

Trump’s healthcare cabinet picks: Implications for U.S. biopharma

News and Trends 29 Nov 2024

Trump’s healthcare picks: Who they are and what they mean for the biopharma industry

Trump’s nominees for top healthcare roles have sparked significant debate. So, what do their appointments signal for the future of healthcare in the U.S.?

November 29, 2024 - 11 minutesmins - By Roohi Mariam Peter

Tuberculosis research

In Depth 6 Nov 2024

Tuberculosis research: Are we finally close to developing a more effective treatment option?

Learn more about the positive advancements that have been made in tuberculosis research in an attempt to find new treatment options.

November 6, 2024 - 12 minutesmins - By Willow Shah-Neville

bird flu vaccines

News and Trends 30 Sep 2024

The race for a bird flu vaccine: milestones and breakthroughs

The recent uptick in U.S. bird flu cases poses a threat to public health. Biotechs are now developing vaccines to mitigate the outbreak.

September 30, 2024 - 10 minutesmins - By Roohi Mariam Peter

ADCs that deliver: The secret lies in rigorous characterization

Sponsored by 17 Sep 2024

ADCs that deliver: The secret lies in rigorous characterization

Explore the challenges of ADC characterization, key techniques, and the benefits of partnering with a CDMO for effective development.

September 17, 2024 - 7 minutesmins - By Ute Boronowsky

mpox vaccines

News and Trends 20 Aug 2024

Fighting mpox: promising vaccines to watch

As Bavarian Nordic ramps up production of the only marketed mpox vaccine, a few clinical trials are underway to combat the outbreak.

August 20, 2024 - 6 minutesmins - By Roohi Mariam Peter

siRNA companies

Best in Biotech 6 Jun 2024

Eight biotech companies advancing the field of siRNA

Explore the growing sector of siRNA and discover eight biotech companies spearheading this innovative field.

June 6, 2024 - 11 minutesmins - By Jules Adam

ADVERTISEMENT

malaria new treatment

In Depth 25 Apr 2024

What are biotech companies doing to tackle malaria?

As we observe World Malaria Day on April 25, let’s take a look at some of the latest progress and new treatments against malaria.

April 25, 2024 - 13 minutesmins - By Roohi Mariam Peter

CRISPR technology

In Depth 4 Apr 2024

Seven diseases CRISPR technology could cure

Here are some of the diseases that scientists aim to tackle using CRISPR technology, testing its possibilities and limits as a medical tool.

April 4, 2024 - 11 minutesmins - By Clara Rodríguez Fernández

RSV vaccine

News and Trends 21 Dec 2023

The big pharma race against deadly RSV steps up in 2023

GSK and Pfizer received FDA approval for their RSV vaccines in 2023. Now, AstraZeneca has joined the race with its latest acquisition.

December 21, 2023 - 7 minutesmins - By Roohi Mariam Peter

Infectious diseases

Best in Biotech 7 Nov 2023

Eight biotech companies tackling infectious diseases head-on

Infectious diseases are diseases that are caused by pathogens that enter the body, hijack the body’s immune system and multiply, causing an infection. Five of the deadliest infectious diseases are measles, tuberculosis, malaria, diarrhoeal disease and influenza, according to the World Economic Forum. While Our World in Data statistics suggest that there has been almost […]

November 7, 2023 - 11 minutesmins - By Roohi Mariam Peter

Glycobiotechnology - AIS biotech

In Depth 11 Jul 2023

AIS Biotech: startup employs carbohydrates to fight the flu

Keen on discovering novel ways to tackle viral infections, AIS Biotech, a French company based in the Alps, aims to combat influenza, more commonly known as the flu, by leveraging the medicinal promise behind glycobiotechnology. A field that has been gaining momentum over the past decade, glycobiotechnology is the study of complex carbohydrates which has […]

July 11, 2023 - 6 minutesmins - By Roohi Mariam Peter

influenza

News and Trends 29 Jun 2023

AI program finds multiple influenza drug targets

Poolbeg Pharma, a clinical-stage biopharma company focusing on infectious and other prevalent diseases, has announced a breakthrough in its world-first influenza Artificial Intelligence (AI) Programme working with the company CytoReason. Poolbeg’s disease progression data from influenza human challenge trials combined with CytoReason’s broad repositories of curated disease data were analyzed using CytoReason’s AI-led platform. The […]

June 29, 2023 - 2 minutesmins - By Jim Cornall

ADVERTISEMENT